Nutriband Inc. Profile Avatar - Palmy Investing

Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transd…

Biotechnology
US, Orlando [HQ]

Resulting Ratios

9 Records · Starting from 2015
Loading...
End of NTRB's Analysis
CIK: 1676047 CUSIP: 67092M208 ISIN: US67092M2089 LEI: - UEI: -
Secondary Listings
NTRB has no secondary listings inside our databases.